Synopsys, Inc.
SNPS
$435.39
$5.541.29%
| Weiss Ratings | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.79 | |||
| Price History | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.79% | |||
| 30-Day Total Return | -14.75% | |||
| 60-Day Total Return | -13.84% | |||
| 90-Day Total Return | -12.25% | |||
| Year to Date Total Return | -9.81% | |||
| 1-Year Total Return | -22.98% | |||
| 2-Year Total Return | 21.86% | |||
| 3-Year Total Return | 48.25% | |||
| 5-Year Total Return | 230.49% | |||
| 52-Week High % Change | -31.20% | |||
| 52-Week Low % Change | 0.60% | |||
| Price | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $624.80 | |||
| 52-Week Low Price | $427.30 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Jul 11, 2024 | |||
| Valuation | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 66.46B | |||
| Enterprise Value | 63.32B | |||
| Price/Earnings (TTM) | 31.78 | |||
| Earnings Per Share (TTM) | 13.53 | |||
| Earnings Per Share Growth | 48.81% | |||
| Price/Earnings To Growth | 0.65 | |||
| Price/Sales (TTM) | 11.06 | |||
| Price/Book (Q) | 7.14 | |||
| Enterprise Value/Revenue (TTM) | 10.43 | |||
| Price | $435.39 | |||
| Enterprise Value/EBITDA (TTM) | 43.93 | |||
| Enterprise Value/EBIT | 50.46 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 156.19M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650-584-5000 | |||
| Address | 675 Almanor Avenue Sunnyvale, CA 94085 | |||
| Website | www.synopsys.com | |||
| Country | United States | |||
| Year Founded | 1986 | |||
| Profitability | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 20.66% | |||
| Profit Margin | 34.75% | |||
| Management Effectiveness | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.65% | |||
| Return on Equity | 15.95% | |||
| Income Statement | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.07B | |||
| Total Revenue (TTM) | 6.07B | |||
| Revenue Per Share | $38.87 | |||
| Gross Profit (TTM) | 4.94B | |||
| EBITDA (TTM) | 1.44B | |||
| EBIT (TTM) | 1.25B | |||
| Net Income (TTM) | 2.11B | |||
| Net Income Avl. to Common (TTM) | 2.11B | |||
| Total Revenue Growth (Q YOY) | -3.68% | |||
| Earnings Growth (Q YOY) | -31.56% | |||
| EPS Diluted (TTM) | 13.53 | |||
| EPS Diluted Growth (Q YOY) | -34.72% | |||
| Balance Sheet | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.81B | |||
| Cash Per Share (Q) | $24.39 | |||
| Total Current Assets (Q) | 6.32B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.30B | |||
| Current Ratio (Q) | 2.681 | |||
| Book Value Per Share (Q) | $60.18 | |||
| Total Assets (Q) | 13.04B | |||
| Total Current Liabilities (Q) | 2.36B | |||
| Total Debt (Q) | 665.04M | |||
| Total Liabilities (Q) | 3.74B | |||
| Total Common Equity (Q) | 9.30B | |||
| Cash Flow | SNPS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.26B | |||
| Cash from Financing (TTM) | -135.99M | |||
| Net Change in Cash (TTM) | 2.54B | |||
| Levered Free Cash Flow (TTM) | 1.03B | |||
| Cash from Operations (TTM) | 1.43B | |||
